Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-23
2006-05-23
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S125000, C548S128000
Reexamination Certificate
active
07049331
ABSTRACT:
The present invention is directed to novel 1,2,4-thiadiazole derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.
REFERENCES:
patent: 6294534 (2001-09-01), Nargund et al.
patent: 6410548 (2002-06-01), Nargund et al.
patent: 131.373 (1978-06-01), None
patent: 60-11481 (1985-01-01), None
patent: 2-173165 (1990-07-01), None
patent: WO 99/55679 (1999-11-01), None
patent: WO 99/64002 (1999-12-01), None
patent: WO 00/24725 (2000-05-01), None
patent: WO 01/55107 (2001-08-01), None
Chetia et al (1985): STN International CAPLUS database (Columbus, Ohio), Accession No. 1985:471257.
Abraham, W. et al., “Formamidinyl Isothiocyanates-III Addition Nucleophilic Partners to Formamidinoyl Isothyiocyantes”, Tetrahedron 29, 1973, pp. 699-705 (English Translation).
PCT International Search Report, dated Jan. 1, 2003, for PCT Appl. No. PCT/US02/35340.
Abraham, W. et al., “Formamidinoylisothiocyanate—III, Additional Nucleophiler Partner and Formamidinoylisothiocyanate”, Tetrahedron, vol. 29, No. 5, pp. 699-705, Mar. 1973, XP002228008.
Barbier, B et al; “Crystal Structure of 2-benzyl-3-phenyl-5-phenylimino-Δ3-1,2,4-thiadiaoline, C21H17N3S”; Z. Kristallogr.NCS (1998). pp 741-742, vol. 213.
Barnikow, Gunter et al; Regarding the oxidative cyclization of imidoyl-thioureas ; Z. Chem., (1972), pp. 130, vol. 12-No. 4.
Chetia, J.P. et al; “One-Pot Synthesis of 2-Aryl-3-phenyl(benzyl)-5-phenylimino-Δ4-1,2,4-thiadiazolines usingN-Chlorosuccinimide”; Synthesis Communications. Jan. 1985. pp 83-84.
Fawzi, Ahmad B. et al; “SCH-202676 An Allosteric Modulator of Both Agonist and Antagonist Binding to G Protein-Coupled Receptors”; Molecular Pharmacology, (2001). pp 30-37; vol. 59- No. 1.
Goerdeler, Joachim et al; “Herstellung von Acylheterocumulenen aus fünfgliedrigen Ringen mit Hilfe von Phosphinen” Chem. Ber. (1974). pp. 502-507; vol. 107.
Goerdeler, Joachim et al; “Herstellung von (N-Alkylbenzimidoyl)- und (N-Arylbenzimidoyl)carbodiimiden; ihre Umlagerung zu Aminochinazolinen und Dihydro-1,3,5-triazinen”; Chem. Ber. (1986), pp. 3737-3748, vol. 119.
Goerdeler, Joachim et al; “Reaktion von Heterocumulenen mit 5-Alhoxy-3-phenylimino3H-1,2,4-dithiazol”, Chem. Ber. (1976), pp. 848-854, vol. 109.
Goerdeler, Joachim et al; “Reaktionen von 5-limino-Δ3-1,2,4-thiadiazolinen mit Heterocumulenen (Präparative Gesichtspunkte)”: Chem. Ber. (1979): pp. 517-531, vol. 112.
Goerdeler, Joachim et al; “Uber die Zerfallsprodukte von lmino-Δ3-1,2,4-thiadiazolinen”; Chem. Ber. (1979). pp. 1288-1296 vol. 112.
Hagiwara, Kenji et al; Synthesis and Fungicidal Activity of Δ3-1,2,4-Thiadiazolines: Journal of Pesticide Science. (1992) pp. 251-259, vol. 17.
L'Abbe, Gerrit et al: “5-lmino-Δ3-1,2,4-thiadiazoline Derivatives with a Linear N-S . . . O Grouping Synthesis and Crystal Structures”, J Heterocyclic Chem., Nov. 1981, pp. 1309-1317, vol. 18.
Liebscher, Jürgen et al; “Oxidation-assisted synthesis of N-imidoyl-guanidines from N-imidoyl-thioureas”; Z. Chem., (1985). pp. 362-363, vol. 25, No. 10.
Nair, M.D. et al; “Oxidation of N-Phenyl-N-phenylthiocarbamoylbenzamidines with Sulphuryl Chloride & Bromine”; Indian Journal of Chemistry, May 1980, pp. 335-337, vol. 19B.
Neidlein, R. et al; “ Zum Reaktionsverhalten Von N-Acyl-S-Chlorisothiocarbamoylchloriden”; Tetrahedron, (1971), pp 4117-4124, vol. 27.
Wikberg, Jarl E.S.; “Melanocortin receptors: new opportunities in drug recovery”; Exp. Opin. Ther. Patents; (2001), pp. 61-76, vol. 11-No. 1.
Zyabrev, V.S. et al; “Chlorination of Imidoyl Isothiocyanates”: Ukrainskii Khimcheskii Zhurnal; (1995), pp. 55-61, vol. 61, No. 5.
S. Rajappa et al., “A General Synthesis of Thiazoles, Part 3, Comparative Evaluation of Different Functionalised Thioureas as Precursors,” J.C.S. Perkin I, May 1978, pp. 1762-1764.
J. Goerdeler et al, Chem. Ber. 112, pp. 1288-1296 (1979) with English-language translation.
Z. Chem. vol. 25 (1985) No. 10, pp. 362-363 with English-language translation.
J. Goerdeler et al., Chem. Ber. 101, 3475-3490 (1968) with English-language abstract.
Eisinger Magdalena
Fitzpatrick Louis J.
Lee Daniel H.
Pan Kevin
Plata-Salaman Carlos
Appollina Mary
Hal Brent Woodrow
Ortho-McNeil Pharmaceutical , Inc.
Shameem Golam M. M.
LandOfFree
1,2,4-thiadiazole derivatives as melanocortin receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2,4-thiadiazole derivatives as melanocortin receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,4-thiadiazole derivatives as melanocortin receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3592227